Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
Timestops (3)
Tools Used
Topic Overview
Key Takeaways
- Abdominal radiation for high-risk neuroblastoma causes significant pancreatic volume reduction, though clinical insufficiency is underreported.
- Pancreatic dysfunction may be an unrecognized late effect; systematic screening is needed given young patient age at treatment.
- Patients show significant weight percentile drops with decreased fat and muscle mass during neuroblastoma therapy.
- Body composition changes likely reflect overall cancer treatment burden, emphasizing need for nutritional screening during therapy.
- As neuroblastoma survival improves, monitoring long-term radiation effects is as critical as achieving initial cure.
Keywords
Hashtags
Transcript
So, we know radiation improves survival in high-risk neuroblastoma, but what does it do to the rest of the body? Hi, I'm Doctor Sophia Skermorn from Cincinnati Children's, and this study looks at how radiation affects the pancreas and body composition in children with neuroblastoma. This is a retrospective study of 50 children with high-risk neuroblastoma undergoing abdominal radiation therapy. The authors use CT and MRI body segmentation to measure pancreatic volume. Cutaneous fat, and so is muscle area before and after treatment. And the key finding was a significant decrease in pancreatic volume after radiation. While very few patients developed clinically apparent pancreatic insufficiency, the authors point out that this wasn't systematically screened for, and falloff may not be long enough to detect these effects, especially given the young average age of these patients. So this raises concern that pancreatic dysfunction could be an Recognized late effect. In terms of body composition, patients had a significant drop in weight percentile with smaller decreases in fat and muscle, and these likely reflect the overall impact of cancer therapy overall rather than radiation alone, but highlight the importance of nutritional screening during cancer treatments. So, as survival improves, understanding and screening for these long-term effects is becoming just as important as curing the cancer itself.